Related Experiment Video
Updated: Feb 13, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Lower Serum Irisin Levels Are Associated with Increased Vascular Calcification in Hemodialysis Patients
Insights
Lower serum irisin levels are linked to vascular calcification in hemodialysis patients. This finding highlights irisin as a potential biomarker for cardiovascular risk in this population.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Endocrinology
Background:
- Vascular calcification is common and a predictor of mortality in dialysis patients.
- The mechanisms underlying vascular calcification are not fully understood.
- Irisin, a myokine, is a potential factor in vascular calcification among hemodialysis patients.
Purpose of the Study:
- To evaluate serum irisin levels in hemodialysis patients.
- To determine the relationship between serum irisin and vascular calcification.
- To identify other parameters associated with vascular calcification in hemodialysis patients.
Main Methods:
- Cross-sectional study of 150 hemodialysis patients and 38 healthy controls.
- Serum irisin concentrations measured using ELISA.
- Abdominal aortic calcification scores used to assess vascular calcification.
Main Results:
- Hemodialysis patients had significantly lower serum irisin levels compared to controls.
- Lower irisin concentrations were observed in hemodialysis patients with vascular calcification.
- Serum irisin, hemodialysis vintage, and age were independent risk factors for vascular calcification.
Conclusions:
- This study provides the first clinical evidence linking serum irisin to vascular calcification in hemodialysis patients.
- Low irisin levels, prolonged hemodialysis, and advanced age are identified as independent risk factors.
- Irisin may serve as a potential biomarker for vascular calcification in hemodialysis patients.
Background/Aims:
Vascular calcification, which involves an active cellular transformation of vascular smooth muscle cells into bone forming cells, is prevalent and predicts mortality in dialysis patients. Its mechanisms are complex and unclear. We presume that irisin, a newly identified myokine also may play roles in vascular calcification in hemodialysis patients. This study aims to evaluate serum irisin levels and establish their relation to vascular calcification and other parameters in hemodialysis patients.
Methods:
A total of 150 patients on maintenance hemodialysis treatment and 38 age- and sex-matched healthy controls were enrolled in this cross-sectional study. Serum irisin concentrations were measured by ELISA. Vascular calcification was evaluated by abdominal aortic calcification scores.
Results:
Serum irisin concentrations were significantly lower in hemodialysis patients than in controls [52.8 (22.0, 100.0) vs. 460.8 (434.8, 483.4) ng/ml, P<0.01]. In addition, irisin was negatively correlated with the parathyroid hormone level (P=0.01). The HD patients with vascular calcification showed significantly lower serum irisin concentrations [39.0 (21.7, 86.2) vs.79.0 (39.5, 130.2) ng/mL, P<0.01]. Compared with the group without vascular calcification multivariate logistic regression analyses revealed that serum irisin, HD vintage and age were significant independent determinant factors for vascular calcification in HD patients.
Conclusion:
Our results are the first to provide a clinical evidence of the association between serum irisin and vascular calcification in HD patients. Lower irisin levels, long-term hemodialysis and old ages are independent risk factors in HD patients.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Increasing Function
Seedless Vascular Plants
Increased Body Temperature

